Imunon
IMNN
20 hedge funds and large institutions have $1.76M invested in Imunon in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 0 closing their positions.
101% more capital invested
Capital invested by funds: $879K → $1.76M (+$883K)
18% more funds holding
Funds holding: 17 → 20 (+3)
7.62% more ownership
Funds ownership: 6.45% → 14.07% (+7.6%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$58.8K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
+$16.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.03K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$163 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$39.4K |
| 2 |
Morgan Stanley
New York
|
-$6.61K |
| 3 |
Citigroup
New York
|
-$1.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.08K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$197 |
IMNN Hedge Fund Activity: Q4 2025 in Review
20 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2025, worth a combined $1.76M — up 101% from $879K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new IMNN positions and 0 closed out — a net gain of 3 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $1.14M. The largest seller was UBS Group, cutting an estimated $39.4K.
- 20 institutional investors held Imunon (IMNN) as of Q4 2025, up from 17 in Q3 2025.
- Funds reported $1.76M of Imunon stock for Q4 2025, up 101% quarter-over-quarter.
- 3 funds opened new Imunon positions in Q4 2025 and 0 closed out, a net change of +3 holders.
- The largest Imunon buyer in Q4 2025 was Armistice Capital, an estimated $1.14M added.
- The largest Imunon seller in Q4 2025 was UBS Group, an estimated $39.4K sold.
Based on aggregated 13F filings for Q4 2025.